2014
DOI: 10.1136/sextrans-2014-051540
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 24 publications
0
7
1
Order By: Relevance
“…In this survey of university students (a selected population), comprising more than 10,000 young men and women (who were a mean 21.8 years old), the lifetime prevalence of clinically-confirmed, self-reported, GWs was similar between the genders, with an overall 1.3% in males and 1.4% in females. In a US population aged 18–59 years, the prevalence of a positive history of GWs was 7.2% for women, and 4% for men [ 15 ]; in a sample population aged 16–55 years in the Czech Republic, the figures were 6.1% and 5.8% in women and men, respectively [ 20 ]; in a population aged 18–45 years in Estonia, they were 4.6% and 2.8%, respectively [ 21 , 22 ]; and in Denmark the figures were higher, at 10.6% in women and 7.9% in men [ 13 ]. The results of other studies on women of similar age placed their lifetime prevalence of GWs at 12% in Iceland, 11.3% in Sweden, and 9.5% in Norway [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…In this survey of university students (a selected population), comprising more than 10,000 young men and women (who were a mean 21.8 years old), the lifetime prevalence of clinically-confirmed, self-reported, GWs was similar between the genders, with an overall 1.3% in males and 1.4% in females. In a US population aged 18–59 years, the prevalence of a positive history of GWs was 7.2% for women, and 4% for men [ 15 ]; in a sample population aged 16–55 years in the Czech Republic, the figures were 6.1% and 5.8% in women and men, respectively [ 20 ]; in a population aged 18–45 years in Estonia, they were 4.6% and 2.8%, respectively [ 21 , 22 ]; and in Denmark the figures were higher, at 10.6% in women and 7.9% in men [ 13 ]. The results of other studies on women of similar age placed their lifetime prevalence of GWs at 12% in Iceland, 11.3% in Sweden, and 9.5% in Norway [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Data from the crosssectional study conducted in the 4 Nordic countries among 70,000 women showed strong correlation between AGW occurrence and history of a previous STIs (genital chlamydial infection, gonorrhea, genital herpes, and trichomoniasis). 34 More recent data extracted from the cross-sectional survey in the Baltic countries 35 and the cross-sectional Italian study on university students 39 confirmed this association, in both men and women. The same is true for another crosssectional study that included almost 23,000 Danish men.…”
Section: Epidemiological Risk Factors Associated With Agw Developmentmentioning
confidence: 90%
“…Earlier studies that have been reported in the 2000s, such as the Australian Longitudinal Study on Women’s Health 40 and the study from the 4 Nordic countries 34 have reported a positive association between AGWs and oral contraceptives use. More recent studies, however, including the Italian study on university students 39 and the study from the Baltic countries, 35 have failed to report such an association. Differences in oral contraceptive regimens between the 2000s and more recent years may be a possible reason for the conflicting studies’ outcomes.…”
Section: Epidemiological Risk Factors Associated With Agw Developmentmentioning
confidence: 95%
See 1 more Smart Citation
“…The trends observed in this study regarding HPV-related cancer sites, together with the continuously increasing risk of cervical cancer in successive birth cohorts [11] and rising incidence of anal cancer among younger women in Estonia [29] suggest an important role of HPV infection. Recent studies have also shown an increase in the prevalence of genital warts in Estonia [30]. HPV vaccination, expected to have a protective role against HPV-associated cancers, is available for girls in the national immunization program in Estonia only since 2018.…”
Section: Incidencementioning
confidence: 99%